Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study
BioScience Trends · 2023
DOI: 10.5582/bst.2022.01476 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift BioScience Trends, 2023. Verfasst von Liang Fu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division Two of Pulmonary Diseases Department, The Third People's Hospital of Shenzhen, National clinical research center for infectious disease, Sou…. Hauptthemen laut MEDLINE: Latent Tuberculosis, Tuberculosis, Mycobacterium tuberculosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Mycobacterium tuberculosis (M.tb) infects a quarter of the world's population and may progress to active tuberculosis (ATB). There is no gold standard for diagnosing latent tuberculosis infection (LTBI). Some immunodiagnostic tests are recommended to detect LTBI but can not distinguish ATB from LTBI. The breath test is useful for diagnosing ATB compared to healthy subjects but was never studied for LTBI. This proof-of-concept study (Chinese Clinical Trials Registry number: ChiCTR2200058346) was the first to explore a novel, rapid, and simple LTBI detection method via breath test on high-pressure photon ionization time-of-flight mass spectrometry (HPPI-TOFMS). The case group of LTBI subjects (n = 185) and the control group (n = 250), which included ATB subgroup (n = 121) and healthy control (HC) subgroup (n = 129), were enrolled. The LTBI detection model indicated that a breath test via HPPI-TOFMS could distinguish LTBI from the control with a sensitivity of 80.0% (95% CI: 67.6%, 92.4%) and a specificity of 80.8% (95% CI: 71.8%, 89.9%). Nevertheless, further intensive studies with a larger sample size are required for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division Two of Pulmonary Diseases Department, The Third People's Hospital of Shenzhen, National clinical research center for infectious disease, Southern University of Science and Technology, Shenzhen, Guangdong, China.
- Breax Laboratory, PCAB Research Center of Breath and Metabolism, Beijing, China.
- Guangdong Key Lab for Diagnosis & Treatment of Emerging Infectious Disease, The Third People's Hospital of Shenzhen, National clinical research center for infectious disease, Southern University of Science and Technolog…
- Medical Examination Department, The Third People's Hospital of Shenzhen, National clinical research center for infectious disease, Southern University of Science and Technology, Shenzhen, Guangdong, China.
- Pulmonary Diseases Out-patient Department, The Third People's Hospital of Shenzhen, National clinical research center for infectious disease, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Zitieren
APA
Fu, L., Feng, Y., Ren, T., Yang, M., Yang, Q., Lin, Y., Zeng, H., Zhang, J., Liu, L., Li, Q., He, M., Zhang, P., Chen, H., & Deng, G. (2023). Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study. BioScience Trends. https://doi.org/10.5582/bst.2022.01476
Vancouver
Fu L, Feng Y, Ren T, Yang M, Yang Q, Lin Y, et al. Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study. BioScience Trends. 2023. doi:10.5582/bst.2022.01476
BibTeX
@article{Fu2023,
author = {Fu, Liang and Feng, Yong and Ren, Tantan and Yang, Min and Yang, Qianting and Lin, Yi and Zeng, Hui and Zhang, Jiaohong and Liu, Lei and Li, Qingyun and He, Mengqi and Zhang, Peize and Chen, Haibin and Deng, Guofang},
title = {Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study},
journal = {BioScience Trends},
year = {2023},
doi = {10.5582/bst.2022.01476}
}
EUVIMED